ストックスクリーナーアプリを入手
10.28
1.72%
-0.18
アフターアワーズ：
10.70
0.42
+4.09%
前日終値:
$10.46
開ける：
$9.91
24時間の取引高:
43,340
Relative Volume:
0.05
時価総額：
$9.47M
収益：
$4.03M
当期純損益:
$24.32M
株価収益率:
-2.3903
EPS:
-4.3008
ネットキャッシュフロー:
$-45.76M
1週間 パフォーマンス:
-2.84%
1か月 パフォーマンス:
+26.45%
6か月 パフォーマンス:
-22.51%
1年 パフォーマンス:
-48.86%
1日の値動き範囲:
$9.655
$10.44
1週間の範囲:
$9.655
$11.34
52週間の値動き範囲:
$6.00
$28.44
Pavmed Inc Stock (PAVM) Company Profile
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
10.28 | 9.64M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 開始されました | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 開始されました | Maxim Group | Buy |
Pavmed Inc (PAVM) 最新ニュース
Signal Recap: Will PAVmed Inc stock hit new highs in YEARInsider Buying & Real-Time Volume Triggers - baoquankhu1.vn
Aug Sectors: Is PAVmed Inc a potential multi baggerWeekly Gains Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed raises $45 million, restructures capital to eliminate convertible debt - Investing.com
PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.com - Investing.com India
PAVmed Restructures Capital With New Preferred Financing - TipRanks
PAVmed Signs Multiple Financing Agreements - TradingView
PAVmed wipes out legacy convertibles in $45M balance-sheet reset - Stock Titan
PAVmed Inc. announced that it expects to receive $30 million in funding - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Technical Analysis: Is PAVmed Inc a stock for growth or value investorsMarket Performance Recap & High Return Trade Opportunity Guides - baoquankhu1.vn
Is PAVmed Inc. stock a value trapJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - mfd.ru
What makes PAVmed Inc. stock attractive todayM&A Rumor & Consistent Profit Trading Strategies - mfd.ru
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
PAVmed Regains Compliance with Nasdaq Minimum Bid Price - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Individual investors among Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest stockholders and were hit after last week's 14% price drop - simplywall.st
What's Going On With PAVmed Shares Thursday? - Benzinga
Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - MEXC
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares - TechStock²
Lucid Diagnostics secures VA contract for esophageal cancer test By Investing.com - Investing.com Nigeria
Crypto: PAVM at Critical Level: Why This Week Matters - InteractiveCrypto
PAVmed Inc. Stock (PAVM) Opinions on VA Contract Win - Quiver Quantitative
Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates - Benzinga
PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs? - Stocktwits
Why Is PAVmed Stock Skyrocketing Wednesday? - Benzinga
PAVM stock shot up over 250% today – what’s the deal with the Department of Veterans Affairs? - MSN
Dow Surges 300 Points; Netflix Shares Fall After Q4 Results - Benzinga
PAVmed Shares Soar Amid Strategic Developments and Market Reactions - timothysykes.com
Lucid Diagnostics stock surges after securing VA contract for cancer test By Investing.com - Investing.com South Africa
Lucid Diagnostics stock surges after securing VA contract for cancer test - Investing.com Canada
PAVmed-unit Lucid Diagnostics spikes on VA contract (LUCD) - Seeking Alpha
Lucid Diagnostics secures VA contract for esophageal cancer test - Investing.com
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® – Company Announcement - Financial Times
PAVMED announces 1-for-30 reverse stock split - MSN
Trade Recap: Is PAVmed Incs ROE strong enoughJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Can PAVmed Inc. stock deliver consistent earnings growthDividend Hike & Community Verified Trade Signals - bollywoodhelpline.com
S P Trends: Is PAVmed Inc stock a top performer YTDWeekly Investment Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
Aug Patterns: Can Ciena Corporation withstand a market correctionJuly 2025 Institutional & Stepwise Trade Signal Guides - baoquankhu1.vn
Treasury Yields: Will AngioDynamics Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn
Bull Bear: Will PAVmed Inc stock hit new highs in YEAR2025 Institutional Moves & Verified Entry Point Detection - baoquankhu1.vn
Movement Recap: Can PAVmed Inc stock deliver 10 annual returns2025 EndofYear Setup & Verified Swing Trading Watchlists - Bộ Nội Vụ
Update Report: Why retail investors favor PAVmed Inc stock2025 Institutional Moves & Real-Time Market Sentiment Alerts - Bộ Nội Vụ
Bond Watch: Is PAVmed Inc. stock a buy on dips2025 Investor Takeaways & Reliable Entry Point Alerts - Bộ Nội Vụ
Pavmed Inc (PAVM) 財務データ
収益
当期純利益
現金流量
EPS
0.45%
0.31%
大文字化:
|
ボリューム (24 時間):